Tag Archives: Clinical Trials in Alzheimer’s Disease congress (CTAD) 2024

Roche Showcases Advancements in Alzheimer’s Diagnostics at CTAD 2024

(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in … Read the full press release